Review



rpa70 antibody  (Bio-Techne corporation)


Bioz Verified Symbol Bio-Techne corporation is a verified supplier
Bioz Manufacturer Symbol Bio-Techne corporation manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    Bio-Techne corporation rpa70 antibody
    Rpa70 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 91/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rpa70 antibody/product/Bio-Techne corporation
    Average 91 stars, based on 8 article reviews
    rpa70 antibody - by Bioz Stars, 2026-04
    91/100 stars

    Images



    Similar Products

    91
    Bio-Techne corporation rpa70 antibody
    Rpa70 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rpa70 antibody/product/Bio-Techne corporation
    Average 91 stars, based on 1 article reviews
    rpa70 antibody - by Bioz Stars, 2026-04
    91/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology santa cruz sc 28304 rpa70 antibody novus nb100
    Santa Cruz Sc 28304 Rpa70 Antibody Novus Nb100, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/santa cruz sc 28304 rpa70 antibody novus nb100/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    santa cruz sc 28304 rpa70 antibody novus nb100 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    92
    Novus Biologicals rpa70
    Fig. 6. In vitro and in vivo effect of ssDNA abrogation in Er1−/− pancreata. (A) <t>RPA70</t> in nuclear and cytoplasmic extracts from wt and Er1−/− pancreata (n = 4). (B) Immunoprecipitation (IP) using anti-ssDNA in untreated or S1 nuclease–treated cytoplasmic extracts from Er1−/− pancreata for RPA70. The input (INP) and flow through (FTH) are 1/20 of the extract used (n = 3). (C) RPA70 in whole-cell extracts of wt and Er1−/− PPCs, untreated, or incubated with scrambled (sictrl) or siRNA against Rpa70 (siRPA70) (n = 4). (D) Immunostaining of ssDNA in wt and Er1−/− PPCs, untreated, or incubated with scrambled (sictrl) or siRNA against Rpa70 (siRPA70) (n = 3). (E) Immunostaining of ssDNA upon recombinant S1 nuclease transfection in untreated and MMC-treated (10 g/ml; 4 hours) wt PPCs (n = 3). (F) Immunostaining of NF-B upon recombinant S1 nuclease transfection in untreated and MMC-treated (10 g/ml; 4 hours) wt PPCs (n = 3). (G) Ifn mRNA levels in MMC-treated wt PPCs, untreated, or transfected with S1 nuclease (n = 5). The graphs in (A) and (C) represent the -TUB– or fibrillarin (FBL)–normalized expression of RPA70 levels (n.e.l.) in Er1−/− compared to corresponding wt controls, as indicated. The graphs in (D) to (F) depict the MFI per cell. All tissues and cells are derived from P15 mice. Scale bars, 5 m. Error bars indicate SEM among n ≥ 3 replicates.
    Rpa70, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rpa70/product/Novus Biologicals
    Average 92 stars, based on 1 article reviews
    rpa70 - by Bioz Stars, 2026-04
    92/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 6. In vitro and in vivo effect of ssDNA abrogation in Er1−/− pancreata. (A) RPA70 in nuclear and cytoplasmic extracts from wt and Er1−/− pancreata (n = 4). (B) Immunoprecipitation (IP) using anti-ssDNA in untreated or S1 nuclease–treated cytoplasmic extracts from Er1−/− pancreata for RPA70. The input (INP) and flow through (FTH) are 1/20 of the extract used (n = 3). (C) RPA70 in whole-cell extracts of wt and Er1−/− PPCs, untreated, or incubated with scrambled (sictrl) or siRNA against Rpa70 (siRPA70) (n = 4). (D) Immunostaining of ssDNA in wt and Er1−/− PPCs, untreated, or incubated with scrambled (sictrl) or siRNA against Rpa70 (siRPA70) (n = 3). (E) Immunostaining of ssDNA upon recombinant S1 nuclease transfection in untreated and MMC-treated (10 g/ml; 4 hours) wt PPCs (n = 3). (F) Immunostaining of NF-B upon recombinant S1 nuclease transfection in untreated and MMC-treated (10 g/ml; 4 hours) wt PPCs (n = 3). (G) Ifn mRNA levels in MMC-treated wt PPCs, untreated, or transfected with S1 nuclease (n = 5). The graphs in (A) and (C) represent the -TUB– or fibrillarin (FBL)–normalized expression of RPA70 levels (n.e.l.) in Er1−/− compared to corresponding wt controls, as indicated. The graphs in (D) to (F) depict the MFI per cell. All tissues and cells are derived from P15 mice. Scale bars, 5 m. Error bars indicate SEM among n ≥ 3 replicates.

    Journal: Science advances

    Article Title: R-loops trigger the release of cytoplasmic ssDNAs leading to chronic inflammation upon DNA damage.

    doi: 10.1126/sciadv.abj5769

    Figure Lengend Snippet: Fig. 6. In vitro and in vivo effect of ssDNA abrogation in Er1−/− pancreata. (A) RPA70 in nuclear and cytoplasmic extracts from wt and Er1−/− pancreata (n = 4). (B) Immunoprecipitation (IP) using anti-ssDNA in untreated or S1 nuclease–treated cytoplasmic extracts from Er1−/− pancreata for RPA70. The input (INP) and flow through (FTH) are 1/20 of the extract used (n = 3). (C) RPA70 in whole-cell extracts of wt and Er1−/− PPCs, untreated, or incubated with scrambled (sictrl) or siRNA against Rpa70 (siRPA70) (n = 4). (D) Immunostaining of ssDNA in wt and Er1−/− PPCs, untreated, or incubated with scrambled (sictrl) or siRNA against Rpa70 (siRPA70) (n = 3). (E) Immunostaining of ssDNA upon recombinant S1 nuclease transfection in untreated and MMC-treated (10 g/ml; 4 hours) wt PPCs (n = 3). (F) Immunostaining of NF-B upon recombinant S1 nuclease transfection in untreated and MMC-treated (10 g/ml; 4 hours) wt PPCs (n = 3). (G) Ifn mRNA levels in MMC-treated wt PPCs, untreated, or transfected with S1 nuclease (n = 5). The graphs in (A) and (C) represent the -TUB– or fibrillarin (FBL)–normalized expression of RPA70 levels (n.e.l.) in Er1−/− compared to corresponding wt controls, as indicated. The graphs in (D) to (F) depict the MFI per cell. All tissues and cells are derived from P15 mice. Scale bars, 5 m. Error bars indicate SEM among n ≥ 3 replicates.

    Article Snippet: 53BP1 (NB100-304; IF: 1300), RPA70 (NB100-2204; WB: 1/1000), TOP1 (NBP1-30482; WB: 1/1000), and goat anti-mouse IgM 550 (NB120-9167R; IF: 1/200) were from Novus Biologicals.

    Techniques: In Vitro, In Vivo, Immunoprecipitation, Incubation, Immunostaining, Recombinant, Transfection, Expressing, Derivative Assay